Stockreport

Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position [Yahoo! Finance]

Rocket Pharmaceuticals, Inc.  (RCKT) 
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rocketpharma.com
PDF target on Rocket Pharmaceuticals to $8 from $10 and kept a Buy rating on the shares following an updated cash position that was made after the company announced its Q3 2 [Read more]